A Study to Learn More About How Radium-223 is Being Used With Other Treatments in European Patients Who Have Not Received Radium-223 Before

Clinical trial NCT04587427 · COMPLETED

Trial details

NCT number: NCT04587427
Sponsor: Bayer
Status: COMPLETED
Study type: OBSERVATIONAL

Bone Metastatic Castration-resistant Prostate Cancer

Start date: 2021-05-15
Primary completion: 2023-05-30
Enrollment: 1067

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.